Biosig Technologies, Common Stock Today
| BSGM Stock | USD 0.55 0.12 17.91% |
PerformanceVery Weak
| Odds Of DistressAbout Average
|
BioSig Technologies, is selling at 0.55 as of the 24th of March 2025; that is 17.91 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.53. BioSig Technologies, has 46 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. The performance scores are derived for the period starting the 24th of December 2024 and ending today, the 24th of March 2025. Click here to learn more.
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut. Biosig Technologies operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. The company has 14.12 M outstanding shares of which 461.7 K shares are currently shorted by private and institutional investors with about 0.95 trading days to cover. More on BioSig Technologies, Common
Moving together with BioSig OTC Stock
| 0.67 | MDAI | Spectral AI | PairCorr |
| 0.84 | OM | Outset Medical | PairCorr |
| 0.63 | VERO | Venus Concept Earnings Call This Week | PairCorr |
| 0.76 | MODD | Modular Medical | PairCorr |
Moving against BioSig OTC Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
BioSig OTC Stock Highlights
| CEO Founder | Kenneth MBA |
| Business Concentration | Medical Equipment, Medical Devices, Healthcare, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) |
BioSig Technologies, Common [BSGM] is traded as part of a regulated electronic over-the-counter service offered by the NASD. BioSig Technologies, is listed under Medical Equipment category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 6.64 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BioSig Technologies,'s market, we take the total number of its shares issued and multiply it by BioSig Technologies,'s current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. BioSig Technologies, conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 14.12 M outstanding shares of which 461.7 K shares are currently shorted by private and institutional investors with about 0.95 trading days to cover.
BioSig Technologies, Common currently holds about 887 K in cash with (17.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02.
Check BioSig Technologies, Probability Of Bankruptcy
Ownership AllocationBioSig Technologies, Common shows 17.59 percent of its outstanding shares held by insiders and 3.04 percent owned by other corporate entities.
Check BioSig Ownership Details
BioSig Technologies, Risk Profiles
| Risk Adjusted Performance | (0.11) | |||
| Jensen Alpha | (1.05) | |||
| Total Risk Alpha | (0.50) | |||
| Treynor Ratio | (0.88) |
BioSig Stock Against Markets
Picking the right benchmark for BioSig Technologies, otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in BioSig Technologies, otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for BioSig Technologies, is critical whether you are bullish or bearish towards BioSig Technologies, Common at a given time. Please also check how BioSig Technologies,'s historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in BioSig Technologies, without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Money Flow Index Now
Money Flow IndexDetermine momentum by analyzing Money Flow Index and other technical indicators |
| All Next | Launch Module |
BioSig Technologies, Corporate Management
Elected by the shareholders, the BioSig Technologies,'s board of directors comprises two types of representatives: BioSig Technologies, inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BioSig. The board's role is to monitor BioSig Technologies,'s management team and ensure that shareholders' interests are well served. BioSig Technologies,'s inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BioSig Technologies,'s outside directors are responsible for providing unbiased perspectives on the board's policies.
| Steven CPA | Chief Officer | Profile | |
| John Sieckhaus | Chief Officer | Profile | |
| Budimir Drakulic | Chief Scientist | Profile | |
| Steven Buhaly | Chief Officer | Profile | |
| Gray Fleming | Chief Officer | Profile | |
| Andrew Ballou | Vice Relations | Profile |
Other Information on Investing in BioSig OTC Stock
BioSig Technologies, financial ratios help investors to determine whether BioSig OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioSig with respect to the benefits of owning BioSig Technologies, security.